Are Resource Constraints Impacting TMF Health?

Quickly expand your internal TMF resources with anytime, anywhere TMF expertise


Phlexglobal TMF Study Owners

Discover why customers rely on Phlexglobal to enhance their TMF Resources

With sponsors facing increasing resource constraints, and CROs struggling to maintain TMF expertise in-house, the TMF has increasingly become a source of added study cost and delay – as well as potential delay or failure of the NDA. 

Phlexglobal helps eliminate these resource risks and help ensure the ongoing health of your TMF project by easily expanding and enhancing your internal TMF capabilities with highly experienced TMF practitioners.


Contact Us



Our TMF practitioners have successfully mastered the challenges you and your teams face every day, averaging 10 years of hands-on experience conducting clinical trials, building TMF processes and SOPs, leading document management teams, implementing regulatory updates, and aligning eTMF technology to business processes.


With one of the largest teams of seasoned TMF professionals in the industry, backed by our tightly aligned in-house services, operations, and technology teams, Phlexglobal offers you TMF expertise that can scale rapidly to any project, anywhere in the world and at any time—regardless of your projects size, complexity, or duration.



Phlexglobal’s TMF Study Owner model provides you with unique flexibility to meet your particular requirements. We have provided everything from a single TMF professional for a two-week engagement at a small biotech and embedded TMF teams to some of the world’s largest pharmaceutical companies and CROs for multi-year engagements. 

Proven Value

We have helped customers improve ongoing inspection-readiness and meet “impossible” deadlines. Phlexglobal frees up internal resources to do more with less and increases your TMF capabilities with a minimal effort.

Digital Brain Header Large Brain Right

It's time to raise your standard 

Contact Us

Latest News

Entering the Post-Paper Realism: The Principles of Cyber Ethics

The Shoulds and Shouldn’ts of Electronic Systems and Data in Clinical Trials Intro With the word should being mentioned 569 times and constituting ~7% of the content (only outweighed by data – 618

Overcoming TMF misfiles and metadata errors to reduce inspection risk

Trial master file misfiles are a common occurrence, with as many as one in every 10 documents being misfiled.   In some ways, misfiles are an even greater issue now with eTMF systems, where filing is

TMF Management in Clinical Trials Blog 3: Running the Trial in Your eTMF

Introduction Well, first and foremost, welcome!   Rob Jones has relinquished control and I’ve been given free rein to bring you the last blog in the series on TMF Management in Clinical Trials. Those